Cargando…

Oxidative Stress in Arterial Hypertension (HTN): The Nuclear Factor Erythroid Factor 2-Related Factor 2 (Nrf2) Pathway, Implications and Future Perspectives

Arterial hypertension (HTN) is one of the most prevalent entities globally, characterized by increased incidence and heterogeneous pathophysiology. Among possible etiologies, oxidative stress (OS) is currently extensively studied, with emerging evidence showing its involvement in endothelial dysfunc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanase, Daniela Maria, Apostol, Alina Georgiana, Costea, Claudia Florida, Tarniceriu, Claudia Cristina, Tudorancea, Ionut, Maranduca, Minela Aida, Floria, Mariana, Serban, Ionela Lacramioara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949198/
https://www.ncbi.nlm.nih.gov/pubmed/35335911
http://dx.doi.org/10.3390/pharmaceutics14030534
_version_ 1784674837664366592
author Tanase, Daniela Maria
Apostol, Alina Georgiana
Costea, Claudia Florida
Tarniceriu, Claudia Cristina
Tudorancea, Ionut
Maranduca, Minela Aida
Floria, Mariana
Serban, Ionela Lacramioara
author_facet Tanase, Daniela Maria
Apostol, Alina Georgiana
Costea, Claudia Florida
Tarniceriu, Claudia Cristina
Tudorancea, Ionut
Maranduca, Minela Aida
Floria, Mariana
Serban, Ionela Lacramioara
author_sort Tanase, Daniela Maria
collection PubMed
description Arterial hypertension (HTN) is one of the most prevalent entities globally, characterized by increased incidence and heterogeneous pathophysiology. Among possible etiologies, oxidative stress (OS) is currently extensively studied, with emerging evidence showing its involvement in endothelial dysfunction and in different cardiovascular diseases (CVD) such as HTN, as well as its potential as a therapeutic target. While there is a clear physiological equilibrium between reactive oxygen species (ROS) and antioxidants essential for many cellular functions, excessive levels of ROS lead to vascular cell impairment with decreased nitric oxide (NO) availability and vasoconstriction, which promotes HTN. On the other hand, transcription factors such as nuclear factor erythroid factor 2-related factor 2 (Nrf2) mediate antioxidant response pathways and maintain cellular reduction–oxidation homeostasis, exerting protective effects. In this review, we describe the relationship between OS and hypertension-induced endothelial dysfunction and the involvement and therapeutic potential of Nrf2 in HTN.
format Online
Article
Text
id pubmed-8949198
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89491982022-03-26 Oxidative Stress in Arterial Hypertension (HTN): The Nuclear Factor Erythroid Factor 2-Related Factor 2 (Nrf2) Pathway, Implications and Future Perspectives Tanase, Daniela Maria Apostol, Alina Georgiana Costea, Claudia Florida Tarniceriu, Claudia Cristina Tudorancea, Ionut Maranduca, Minela Aida Floria, Mariana Serban, Ionela Lacramioara Pharmaceutics Review Arterial hypertension (HTN) is one of the most prevalent entities globally, characterized by increased incidence and heterogeneous pathophysiology. Among possible etiologies, oxidative stress (OS) is currently extensively studied, with emerging evidence showing its involvement in endothelial dysfunction and in different cardiovascular diseases (CVD) such as HTN, as well as its potential as a therapeutic target. While there is a clear physiological equilibrium between reactive oxygen species (ROS) and antioxidants essential for many cellular functions, excessive levels of ROS lead to vascular cell impairment with decreased nitric oxide (NO) availability and vasoconstriction, which promotes HTN. On the other hand, transcription factors such as nuclear factor erythroid factor 2-related factor 2 (Nrf2) mediate antioxidant response pathways and maintain cellular reduction–oxidation homeostasis, exerting protective effects. In this review, we describe the relationship between OS and hypertension-induced endothelial dysfunction and the involvement and therapeutic potential of Nrf2 in HTN. MDPI 2022-02-27 /pmc/articles/PMC8949198/ /pubmed/35335911 http://dx.doi.org/10.3390/pharmaceutics14030534 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Tanase, Daniela Maria
Apostol, Alina Georgiana
Costea, Claudia Florida
Tarniceriu, Claudia Cristina
Tudorancea, Ionut
Maranduca, Minela Aida
Floria, Mariana
Serban, Ionela Lacramioara
Oxidative Stress in Arterial Hypertension (HTN): The Nuclear Factor Erythroid Factor 2-Related Factor 2 (Nrf2) Pathway, Implications and Future Perspectives
title Oxidative Stress in Arterial Hypertension (HTN): The Nuclear Factor Erythroid Factor 2-Related Factor 2 (Nrf2) Pathway, Implications and Future Perspectives
title_full Oxidative Stress in Arterial Hypertension (HTN): The Nuclear Factor Erythroid Factor 2-Related Factor 2 (Nrf2) Pathway, Implications and Future Perspectives
title_fullStr Oxidative Stress in Arterial Hypertension (HTN): The Nuclear Factor Erythroid Factor 2-Related Factor 2 (Nrf2) Pathway, Implications and Future Perspectives
title_full_unstemmed Oxidative Stress in Arterial Hypertension (HTN): The Nuclear Factor Erythroid Factor 2-Related Factor 2 (Nrf2) Pathway, Implications and Future Perspectives
title_short Oxidative Stress in Arterial Hypertension (HTN): The Nuclear Factor Erythroid Factor 2-Related Factor 2 (Nrf2) Pathway, Implications and Future Perspectives
title_sort oxidative stress in arterial hypertension (htn): the nuclear factor erythroid factor 2-related factor 2 (nrf2) pathway, implications and future perspectives
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949198/
https://www.ncbi.nlm.nih.gov/pubmed/35335911
http://dx.doi.org/10.3390/pharmaceutics14030534
work_keys_str_mv AT tanasedanielamaria oxidativestressinarterialhypertensionhtnthenuclearfactorerythroidfactor2relatedfactor2nrf2pathwayimplicationsandfutureperspectives
AT apostolalinageorgiana oxidativestressinarterialhypertensionhtnthenuclearfactorerythroidfactor2relatedfactor2nrf2pathwayimplicationsandfutureperspectives
AT costeaclaudiaflorida oxidativestressinarterialhypertensionhtnthenuclearfactorerythroidfactor2relatedfactor2nrf2pathwayimplicationsandfutureperspectives
AT tarniceriuclaudiacristina oxidativestressinarterialhypertensionhtnthenuclearfactorerythroidfactor2relatedfactor2nrf2pathwayimplicationsandfutureperspectives
AT tudoranceaionut oxidativestressinarterialhypertensionhtnthenuclearfactorerythroidfactor2relatedfactor2nrf2pathwayimplicationsandfutureperspectives
AT maranducaminelaaida oxidativestressinarterialhypertensionhtnthenuclearfactorerythroidfactor2relatedfactor2nrf2pathwayimplicationsandfutureperspectives
AT floriamariana oxidativestressinarterialhypertensionhtnthenuclearfactorerythroidfactor2relatedfactor2nrf2pathwayimplicationsandfutureperspectives
AT serbanionelalacramioara oxidativestressinarterialhypertensionhtnthenuclearfactorerythroidfactor2relatedfactor2nrf2pathwayimplicationsandfutureperspectives